Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges

Nonalcoholic fatty liver disease (NAFLD), a chronic condition associated with metabolic dysfunction and obesity, has reached epidemic proportions worldwide. Although early NAFLD can be treated with lifestyle changes, the treatment of advanced liver pathology, such as nonalcoholic steatohepatitis (NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Haoyu, Zhang, Shuairan, Liu, Ying, Wu, Yifan, Zhang, Dianbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003526/
https://www.ncbi.nlm.nih.gov/pubmed/36902015
http://dx.doi.org/10.3390/ijms24054583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003526/
https://www.ncbi.nlm.nih.gov/pubmed/36902015
http://dx.doi.org/10.3390/ijms24054583

Ejemplares similares